Entyvio

Vedolizumab

Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Millennium Pharmaceuticals, Inc. for the treatment of ulcerative colitis and Crohn's disease.[3] It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7).[3][4] Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity.[5]...

Anyone had success with Entyvio for Ulcerative Colitis? ## Hello, Jennifer! How are you? When do you start them? The FDA lists Entyvio as containing the active ingredient Vedolizumab and it is approved to treat UC. Its possible side effects may include headache, joint pain, nausea, fever and infections of the nose and throat. Is anyone currently on this? ## Yes, after 6 months remission.

2 REPLIES

Drug Index

Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Millennium Pharmaceuticals, Inc. for the treatment of ulcerative colitis and Crohn's disease.[3] It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7).[3][4] Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity.[5]...

NDC Database

Entyvio 300 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Takeda Pharmaceuticals America, Inc. ## Package Codes: 64764-300-20 ## Active Ingredients: Vedolizumab